Active MPN Research
With many clinical trials in progress, as well as clinicians and laboratory scientists around the world researching MPNs, our understanding of these diseases continues to grow. New research on the causes and treatment of MPNs is constantly being published. Here you can find links to the latest MPN research publications.
- Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
- Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.
- Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
- Magnetic Resonance Imaging correlates of benign and malignant alterations of the spinal bone marrow.
- Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy.
- Ruxolitinib for essential thrombocythemia?
- Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
- Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
- Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data.
- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.
- Shedding New Light on the Magnitude of Thrombosis Risk in Patients With Myeloproliferative Neoplasms.
- Sequential Conditioning with Thiotepa in T-Cell Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematological Malignancies: Comparison with Matched Related, Haplo-Mismatched and Unrelated Donors.
- Infections associated with ruxolitinib: study in the French Pharmacovigilance database.
- Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.
- The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision.